Jung-Min Lee

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Diffusion Weighted

Top Venues

Cancer research

Radiology. Artificial intelligence

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to mitigate R-loop-induced replication stress in ovarian cancer. Cancer research (2024)
Benjamin Hou, Sung-Won Lee, Jung-Min Lee, Christopher Koh, Jing Xiao, Perry J. Pickhardt, Ronald M Summers
Deep Learning Segmentation of Ascites on Abdominal CT Scans for Automatic Volume Quantification. Radiology. Artificial intelligence 6 (5) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair, Kelli M Wilson, Ken Cheng, Jung-Min Lee
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer. Cancer research 84 (6) (2024)
Benjamin Hou, Sung-Won Lee, Jung-Min Lee, Christopher Koh, Jing Xiao, Perry J. Pickhardt, Ronald M Summers
Deep Learning Segmentation of Ascites on Abdominal CT Scans for Automatic Volume Quantification. Radiology. Artificial intelligence 6 (5) (2024)
Benjamin Hou, Sung-Won Lee, Jung-Min Lee, Christopher Koh, Jing Xiao, Perry J. Pickhardt, Ronald M Summers
Deep Learning Segmentation of Ascites on Abdominal CT Scans for Automatic Volume Quantification. Radiology. Artificial intelligence (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair, Daniel An, Grant Zurcher, Erika J Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M Swisher, Marc R Radke, Christina M Lockwood, Jonathan B Reichel, Chih-Yuan Chiang, Kelli M Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA -mutant ovarian cancer. Science translational medicine 15 (701) (2023)
Jung-Min Lee, Joyce F Liu
One fixed dosing of a poly(adenosine diphosphate ribose) polymerase inhibitor does not fit all. Cancer (2023)
Jung-Min Lee, Richard G Moore, Sharad A Ghamande, Min S Park, John P Diaz, Julia Chapman, James Kendrick, Brian M Slomovitz, Krishnansu S Tewari, Elizabeth S Lowe, Tsveta Milenkova, Sanjeev Kumar, Mike Dymond, Jessica Brown, Joyce F Liu
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Tzu-Ting Huang, Sandra Sczerba Burkett, Mayank Tandon, Tomomi M Yamamoto, Nitasha Gupta, Benjamin G Bitler, Jung-Min Lee, Jayakumar R Nair
Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer. Oncogene 41 (46) (2022)
Daniel S Green, Franklin Ning, Anna Duemler, Timothy G Myers, Kathryn Trewitt, Irene Ekwede, Ann McCoy, Nicole Houston, Jung-Min Lee, Stanley Lipkowitz, Alexandra S Zimmer, Miroslava Pavelova, Erin N Villanueva, Leslie Smith, Andrew M Blakely, Yovanni Casablanca, Steven L Highfill, David F Stroncek, Naoza Collins-Johnson, Sandhya R Panch, JoLynn Procter, Chauha Pham, Steven M Holland, Lindsey B Rosen, Ana T Nunes, Kathryn C Zoon, Christopher B Cole, Christina M Annunziata
Intraperitoneal monocytes and interferons as a novel cellular immunotherapy for ovarian cancer: mechanistic characterization and results of a phase I clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jung-Min Lee, Lori M Minasian, Elise C Kohn
New strategies in ovarian cancer treatment. Cancer (2020)